Iran International
rightDEVELOPINGInsulin costs soar in Iran as insurance fails to keep up
Rising drug prices and lagging insurance coverage are pushing diabetes medication further out of reach in Iran, documents obtained by Iran International show, with one patient’s NovoMix FlexPen insulin payment rising more than 24-fold in less than two months.
Full BriefGenerated 0m ago
Rising drug prices and lagging insurance coverage are pushing diabetes medication further out of reach in Iran, documents obtained by Iran International show, with one patient’s NovoMix FlexPen insulin payment rising more than 24-fold in less than two months.
This page aggregates and summarizes reporting from Iran International. The Conflict Pulse does not author original reporting. Read the original source for full coverage.
CONFLICT OVERVIEW
Iran
Latest verified updates on Iran’s regional confrontation, U.S.–Israeli strikes, missile retaliation, proxy networks, sanctions, and Strait of Hormuz risks.
SOURCE PERSPECTIVES
How outlets across the bias spectrum are covering this conflict.
LATEST FROM IRAN
